AIM: To evaluate susceptibility of Helicobacter pylori to amoxicillin and clarithromycin in end-stage renal disease (ESRD) patients and non-uremic controls. MET
Background and study aims: Although surgery remains the gold standard for the treatment of symptomatic common bile duct stenosis associated with chronic pancrea
AIM: Human β-defensin (HBD)-1 and HBD-2 are endogenous antimicrobial peptides. Unlike HBD-1, the HBD-2 expression is augmented by Helicobacter pylori(H pylori)